Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07738432

Neuro-MoD: Neuroplasticity With Motor Development

This study is for infants and toddlers between 8 and 24 months old who use one arm and/or hand differently following a perinatal brain injury. This is a time when investigators think they can best help improve how the brain controls movement. Investigators are testing whether the combination of transcutaneous auricular vagus nerve stimulation (taVNS) with 40 hours of constraint-induced movement therapy (CIMT) can help infants move their weaker arm and hand better and make the brain pathways for movement stronger.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

About this study

Primary Objective • To evaluate the feasibility of using spTMS to elicit motor-evoked potentials (MEPs) in infants with hemiplegic cerebral palsy (CP) due to perinatal brain injury and to determine whether baseline MEP characteristics predict motor response to a 40-hour intervention combining taVNS with CIMT.

Exploratory Objective:

  • To investigate neuroplastic changes in cortical motor circuitry associated with taVNS-paired CIMT by examining longitudinal changes in MEP topography and corresponding motor function.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Infants aged 8 to 24 months, diagnosed with hemiplegia or with an evident unilateral upper-limb weakness due to perinatal brain injury
  • Gross Motor Function Classification System (GMFCS) level I-IV
  • Infants who have not received previous CIMT in the preceding 3 months
  • Able to make consecutive appointments for assessments and intervention over 2 weeks, and complete the 3-month follow-up.

Exclusion criteria

  • GMFCS level V
  • Prior CIMT within the past 3 months
  • Severe motor impairment/quadriplegic involvement.
  • Uncontrolled seizure disorders, cardiomyopathy, severe congenital malformations,
  • significant sensory impairments, or conditions preventing safe participation in therapy sessions

Treatment and study plan

Constraint-Induced Movement Therapy (CIMT)

Behavioral

CIMT involves placing a mitt constraint on the stronger arm and hand while encouraging your child to use the weaker arm and hand during intensive therapy sessions.

Transcutaneous Auricular Vagus Nerve Stimulation (taVNS)

Device

Stimulates a nerve by the ear, called the vagus nerve, that may enhance learning motor skills.

Primary outcomes

  1. Proportion of participants in whom MEPs can be elicited reliably at baseline (presence/absence)

    Time frame: baseline (Day 1)

    Motor-evoked potentials (MEPs) are electrical responses recorded from a muscle following a brief magnetic pulse delivered to the brain using single-pulse transcranial magnetic stimulation (spTMS). This outcome measures the proportion of participants in whom a reliable MEP can be elicited at baseline and serves as a measure of the feasibility of assessing corticospinal connectivity in infants with perinatal brain injury.

  2. Completion rate of spTMS sessions

    Time frame: baseline (Day 1), post-intervention (Day 12), 3 month follow-up

    This outcome measures the proportion of planned spTMS assessment sessions that are successfully completed at baseline, post-intervention, and 3-month follow-up. Completion rates will be used to evaluate the feasibility, tolerability, and practicality of conducting repeated spTMS assessments in infants and toddlers with perinatal brain injury.

Secondary outcomes

  1. Baseline MEP Amplitude

    Time frame: baseline (Day 1), post-intervention (Day 12), 3 month follow-up

    MEP amplitude will be reported in millivolts (mV), measured from electromyography recordings of the target muscle.

  2. Percent change in Mini-Assisting Hand Assessment (mini-AHA) score from baseline to end of treatment

    Time frame: baseline (Day 1), post-intervention (Day 12), 3 month follow-up

    The mini-AHA evaluates how effectively infants with unilateral upper extremity impairment use their affected hand during bimanual play activities. Scores are reported on a standardized 0-100 scale, with higher scores indicating greater functional use of the affected hand and lower scores indicating less functional use.

  3. Change in Quality of Upper Extremity Skills Test (QUEST) score from baseline

    Time frame: baseline (Day 1), post-intervention (Day 12), 3 month follow-up

    This is a measure of movement, scored in several domains: dissociated movement (joint mobility), grasp (holding and manipulating objects), protective extension (reflex reactions), and weight bearing assessments. It is scored from 0 to 100 where higher scores mean better movement.

    Change in QUEST score from baseline will be used to assess changes in upper extremity function following the intervention.

  4. Bayley Scales of Infant Development (Bayley-4; Fine Motor subtest)

    Time frame: baseline (Day 1), post-intervention (Day 12), 3 month follow-up

    The Bayley Scales of Infant and Toddler Development, Fourth Edition (Bayley-4) Fine Motor subtest evaluates fine motor skills, including reaching, grasping, object manipulation, and hand-eye coordination. Scores are standardized based on age and range from 1 to 19, with a normative mean of 10 and standard deviation of 3. Scores in the range of 8-12 are generally considered within the typical range for age. Higher scores indicate more advanced motor development.

  5. Bayley Scales of Infant Development (Bayley-4; Gross Motor subtests)

    Time frame: baseline (Day 1), post-intervention (Day 12), 3 month follow-up

    The Bayley Scales of Infant and Toddler Development, Fourth Edition (Bayley-4) Gross Motor subtest evaluates gross motor skills, including posture, sitting, crawling, standing, walking, and other age-appropriate movement abilities. Scores are standardized based on age and range from 1 to 19, with a normative mean of 10 and standard deviation of 3. Scores in the range of 8-12 are generally considered within the typical range for age. Higher scores indicate more advanced motor development.

  6. Gross Motor Function Measure (GMFM-88)

    Time frame: baseline (Day 1), post-intervention (Day 12), 3 month follow-up

    The Gross Motor Function Measure-88 (GMFM-88) evaluates gross motor function across five domains: lying and rolling, sitting, crawling and kneeling, standing, and walking, running, and jumping. Items are scored on a 4-point scale and converted to dimension and total scores ranging from 0 to 100. Higher scores indicate better gross motor function and greater ability to perform age-appropriate motor activities.

Other outcomes

  1. MEP Amplitude

    Time frame: baseline (Day 1), post-intervention (Day 12), 3 month follow-up

    Motor-evoked potential (MEP) amplitude measures the strength of the muscle response produced after a brief magnetic pulse is applied to the brain using single-pulse transcranial magnetic stimulation (spTMS). Larger amplitudes indicate stronger communication between the brain and the target muscle. MEP amplitude will be reported in millivolts (mV).

  2. MEP Threshold

    Time frame: baseline (Day 1), post-intervention (Day 12), 3 month follow-up

    Motor-evoked potential (MEP) threshold is the minimum level of magnetic stimulation needed to produce a muscle response. Lower thresholds generally indicate that the pathway between the brain and muscle can be activated more easily. MEP threshold will be reported as a percentage of maximum stimulator output (%MSO).

  3. Cortical Map Topography

    Time frame: baseline (Day 1), post-intervention (Day 12), 3 month follow-up

    Cortical map topography describes the location and distribution of brain areas that produce muscle responses when stimulated using single-pulse transcranial magnetic stimulation (spTMS). Changes in the size, location, or organization of these areas over time may reflect changes in brain connectivity and neuroplasticity.

Study contacts

Contact information is provided by the study sponsor or research team.

Arun Karumattu Manattu, PhD

CONTACT

[email protected]

608-381-2699

Bernadette Gillick, PhD, MSPT

CONTACT

[email protected]

608-262-7457

Sponsors and collaborators

Lead sponsor

University of Wisconsin, Madison

Other

Registry information

Official study title

Harnessing Early Neuroplasticity in Infants With Perinatal Brain Injury: A Study of Combined Transcutaneous Auricular Vagal Nerve Stimulation (taVNS) Paired With Constraint Induced Movement Therapy (CIMT) and Transcranial Magnetic Stimulation (TMS)

Important dates

Study start
2026
Primary completion
2027
Study completion
2027
First posted
Jul 31, 2026
Registry last updated
Jul 31, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.